ASTX727 in Recurrent/Progressive Non-enhancing IDH Mutant Gliomas
Massachusetts General Hospital
Massachusetts General Hospital
M.D. Anderson Cancer Center
Seattle Children's Hospital
University of California, San Francisco
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
Columbia University
EMD Serono
St. Jude Children's Research Hospital
Neonc Technologies, Inc.
The University of Texas Health Science Center, Houston
Jazz Pharmaceuticals
Seattle Children's Hospital
Seattle Children's Hospital
ITM Solucin GmbH
Seattle Children's Hospital
Pfizer
Mayo Clinic
AbbVie
National Cancer Institute (NCI)
Baylor College of Medicine
Plus Therapeutics
Eli Lilly and Company
Thomas Jefferson University
Thomas Jefferson University
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
Children's Oncology Group
Children's Oncology Group
Suzhou Maximum Bio-tech Co., Ltd.
EpicentRx, Inc.
Children's Oncology Group
M.D. Anderson Cancer Center
EMD Serono
St. Jude Children's Research Hospital
Universitätsmedizin Mannheim
The Hospital for Sick Children
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
Y-mAbs Therapeutics
National Cancer Institute (NCI)
Stanford University
Washington University School of Medicine
Children's Oncology Group
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Children's Oncology Group
Children's Hospital Los Angeles
Canadian Cancer Trials Group
Mayo Clinic